Syon Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
22,007
-633
-3% -$48.8K 0.08% 186
2025
Q4
$1.8M Buy
22,640
+1,236
+6% +$97.4K 0.09% 162
2025
Q3
$1.61M Buy
21,404
+4,190
+24% +$287K 0.09% 154
2025
Q2
$1.19M Buy
17,214
+5,404
+46% +$354K 0.08% 178
2025
Q1
$800K Buy
11,810
+4,284
+57% +$256K 0.07% 223
2024
Q4
$338K Buy
7,526
+247
+3% +$13.9K 0.03% 371
2024
Q3
$458K Buy
7,279
+834
+13% +$48.7K 0.04% 293
2024
Q2
$381K Sell
6,445
-5,109
-44% -$320K 0.04% 309
2024
Q1
$922K Sell
11,554
-9,886
-46% -$755K 0.09% 169
2023
Q4
$1.69M Buy
21,440
+13,982
+187% +$995K 0.07% 169
2023
Q3
$521K Buy
+7,458
New +$528K 0.06% 179

Other funds holding CVS

Syon Capital's CVS Position: Q1 2026 in Review

Syon Capital reduced its CVS Health (CVS) stake by 2.8% in Q1 2026, selling an estimated $48.8K and leaving 22,007 shares worth $1.58M. The position accounts for 0.08% of the portfolio, ranked #186.

Syon Capital first reported a position in CVS in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.8M in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Syon Capital held 22,007 shares of CVS Health worth $1.58M as of Q1 2026.
  • Syon Capital sold 633 CVS Health shares in Q1 2026, an estimated $48.8K.
  • CVS Health made up 0.08% of Syon Capital's portfolio in Q1 2026, its #186 holding.
  • Syon Capital first reported a position in CVS Health in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's CVS Health position peaked at $1.8M in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.